Meredith M. Regan

42.0k citations
331 papers · 18.4k indexed · 8 hit papers · h-index 64
Topics
Breast Cancer Treatment Studies (82 papers)Prostate Cancer Treatment and Research (67 papers)Estrogen and related hormone effects (57 papers)

In The Last Decade

Meredith M. Regan

322 papers receiving 18.0k citations

Hit Papers

Prognostic Factors for Overall Survival in Patients With ...20042026201120182009200420202013200450010001.5k

Peers

Meredith M. Regan
Comparison fields: 5 of 171
  • Pulmonary and Respiratory Medicine 7.8k
  • Oncology 6.7k
  • Cancer Research 6.6k
  • Molecular Biology 4.5k
  • Genetics 2.5k
Replace Ian E. Smith with:
Ian E. Smith United Kingdom
Lorelei A. Mucci United States
Rulla M. Tamimi United States
Neil E. Caporaso United States
James M. Ford United States
Teuvo L.J. Tammela Finland
Steve E. Humphries United Kingdom
Ann W. Hsing United States
Vered Stearns United States
Pär Stattin Sweden
Meredith M. Regan relative to Ian E. Smith United Kingdom Ian E. Smith's profile →
Citations per field
00.5×5.4×
Ian E. Smith · 1×
Citations per year

Countries citing papers authored by Meredith M. Regan

Since Specialization
Citations

This map shows the geographic impact of Meredith M. Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith M. Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith M. Regan more than expected).

Fields of papers citing papers by Meredith M. Regan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith M. Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith M. Regan. The network helps show where Meredith M. Regan may publish in the future.

Co-authorship network of co-authors of Meredith M. Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith M. Regan. A scholar is included among the top collaborators of Meredith M. Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith M. Regan. Meredith M. Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 2
5 5
6 6
7 6
8 7
9 51
10 7
11 21
12
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guidelinebreakdown →
592
13 21
14 5
15 110
16 102
17 24
18 32
19 164
20 90

About Meredith M. Regan

Meredith M. Regan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 331 papers that have together received 18.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (82 papers), Prostate Cancer Treatment and Research (67 papers) and Estrogen and related hormone effects (57 papers). The work is most often cited by research in Cancer Research (6.6k citations), Oncology (6.7k citations) and Pulmonary and Respiratory Medicine (7.8k citations). Meredith M. Regan has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Richard D. Gelber, Michael B. Atkins, William Oh, Wanling Xie, Giuseppe Viale, David F. McDermott, Karen N. Price, Alan S. Coates, Beat Thürlimann and Aron Goldhirsch. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026